Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the
company's presentation at the J. P. Morgan Healthcare Conference in San
Francisco, California on January 10, 2012. The live webcast is scheduled
to begin at 9:00 a.m. PT and will feature a brief overview of the
company by Jay Flatley, President and Chief Executive Officer, followed
by a question and answer session.
This webcast can be accessed in the Investor Relations section of
Illumina's web site under the "Company" tab at www.illumina.com.
About Illumina
Illumina (http://www.illumina.com)
is a leading developer, manufacturer, and marketer of life science tools
and integrated systems for the analysis of genetic variation and
function. We provide innovative sequencing and array-based solutions for
genotyping, copy number variation analysis, methylation studies, gene
expression profiling, and low-multiplex analysis of DNA, RNA and
protein. We also provide tools and services that are fueling advances in
consumer genomics and diagnostics. Our technology and products
accelerate genetic analysis research and its application, paving the way
for molecular medicine and ultimately transforming healthcare.
